奥沙利铂联合替吉奥二线治疗晚期胆囊癌的临床效果(4)
[16] Sasaki T，Isayama H，Nakai Y，et al. A randomized phase Ⅱ study of gemcitabine and S -1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer [J]. Cancer Chemother Pharmacol，2013，71(4)：973-979.
[17] Sharma A，Dwary AD，Mohanti BK，et al. Best supportive care compared with chemotherapy for unresectable gall bladder cancer：a randomized controlled study [J]. J Clin Oncol，2010，28(30)：4581-4586.
[18] Kim HS，Kim HY，Zang DY，et al. Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer [J]. Cancer Chemother Pharmacol，2015，75(4)：711-718.
[19] Kim KP，Jang G，Hong YS，et al. Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer：influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity [J]. Br J Cancer，2011，104(4)：605-612.
[20] Oh SY，Lee GW，Kim HG，et al. Phase Ⅱ trial of S-1 in combination with oxaliplatin in previously untreated patients with recurrent or inoperablebiliary tract cancer [J]. Chemotherapy，2008，54(6)：479-484.
[21] Tajima H，Ohta T，Shinbashi H，et al. Successful treatment of unresectable gallbladder cancer with low-dose paclitaxel as palliative chemotherapy after failure of gemcitabine and oral S-1：a case report [J]. Oncol Lett，2012，4(6)：1281-1284.
(收稿日期：2016-01-20 本文编辑：赵鲁枫) (牛楠 刘佳 吴荣 曾越灿)
[17] Sharma A，Dwary AD，Mohanti BK，et al. Best supportive care compared with chemotherapy for unresectable gall bladder cancer：a randomized controlled study [J]. J Clin Oncol，2010，28(30)：4581-4586.
[18] Kim HS，Kim HY，Zang DY，et al. Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer [J]. Cancer Chemother Pharmacol，2015，75(4)：711-718.
[19] Kim KP，Jang G，Hong YS，et al. Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer：influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity [J]. Br J Cancer，2011，104(4)：605-612.
[20] Oh SY，Lee GW，Kim HG，et al. Phase Ⅱ trial of S-1 in combination with oxaliplatin in previously untreated patients with recurrent or inoperablebiliary tract cancer [J]. Chemotherapy，2008，54(6)：479-484.
[21] Tajima H，Ohta T，Shinbashi H，et al. Successful treatment of unresectable gallbladder cancer with low-dose paclitaxel as palliative chemotherapy after failure of gemcitabine and oral S-1：a case report [J]. Oncol Lett，2012，4(6)：1281-1284.
(收稿日期：2016-01-20 本文编辑：赵鲁枫) (牛楠 刘佳 吴荣 曾越灿)